Bio-Rad Laboratories, Inc.Class A vs. Bruker Corporation
Bio-Rad Laboratories, Inc.Class A (BIO) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| BIO | BRKR | |
|---|---|---|
| Market Cap | $10.21 billion | $9.07 billion |
| Revenue (TTM) | $2.59 billion | $3.50 billion |
| Net Income (TTM) | $222.40 million | $-64,500,000 |
BIO leads on 2 of 3 size & scale factors.
Valuation
| BIO | BRKR | |
|---|---|---|
| P/E Ratio | 46.50 | — |
| Price / Book | 1.42 | 3.78 |
| Price / Sales | 3.94 | 2.59 |
BIO and BRKR split the valuation factors evenly.
Profitability
| BIO | BRKR | |
|---|---|---|
| Net Margin | 8.59% | -1.84% |
| Return on Equity | 3.10% | -2.69% |
BIO leads on 2 of 2 profitability factors.
Dividend
| BIO | BRKR | |
|---|---|---|
| Dividend Yield | — | 0.35% |
BIO and BRKR split the dividend factors evenly.
Risk & Sentiment
| BIO | BRKR | |
|---|---|---|
| Short Interest | 2.44% | 1.53% |
BRKR leads on 1 of 1 risk & sentiment factors.
Dig deeper: BIO overview, BIO financials, BRKR overview, BRKR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.